These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25510803)

  • 1. Chemotherapy for treatment of grade II gliomas.
    Strowd RE; Holdhoff M; Grossman SA
    Oncology (Williston Park); 2014 Dec; 28(12):1036-43. PubMed ID: 25510803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
    Levin VA
    Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy for low-grade gliomas: lessons and questions.
    Raizer J
    Oncology (Williston Park); 2014 Dec; 28(12):1043-4, 1051. PubMed ID: 25510804
    [No Abstract]   [Full Text] [Related]  

  • 4. Tailoring chemotherapy for low-grade gliomas.
    Galanis E
    Oncology (Williston Park); 2014 Dec; 28(12):1052, 1071. PubMed ID: 25510805
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy for diffuse low-grade gliomas in adults.
    Ducray F
    Rev Neurol (Paris); 2011 Oct; 167(10):673-9. PubMed ID: 21906770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
    Bouffet E; Mornex F; Jouvet A; Thiesse P; Mertens P; Helfre S; Sindou M; Bret P
    Bull Cancer; 1997 Oct; 84(10):951-6. PubMed ID: 9435796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade gliomas.
    Schiff D
    Continuum (Minneap Minn); 2015 Apr; 21(2 Neuro-oncology):345-54. PubMed ID: 25837900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-grade gliomas: management issues.
    Duran I; Raizer JJ
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S15-21. PubMed ID: 18076313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade gliomas.
    Stieber VW
    Curr Treat Options Oncol; 2001 Dec; 2(6):495-506. PubMed ID: 12057095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas.
    Jakacki RI; Jamison C; Mathews VP; Heilman DK; Dropcho E; Cornetta K; Macdonald DR; Williams DA
    Med Pediatr Oncol; 1998 Dec; 31(6):483-90. PubMed ID: 9835900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
    Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016.
    Rudà R; Pellerino A; Pace A; Carapella CM; Dealis C; Caroli M; Faedi M; Bello L; Migliore E; Marchese G; Bertero L; Cassoni P; Soffietti R
    J Neurooncol; 2019 Oct; 145(1):115-123. PubMed ID: 31556015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centre.
    Keogh RJ; Aslam R; Hennessy MA; Coyne Z; Hennessy BT; Breathnach OS; Grogan L; Morris PG
    BMC Cancer; 2021 Feb; 21(1):140. PubMed ID: 33557783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
    Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
    Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of low-grade gliomas.
    Lesser GJ
    Semin Radiat Oncol; 2001 Apr; 11(2):138-44. PubMed ID: 11285551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic evaluation of low-grade gliomas in adults before and after treatment with CCNU alone.
    Kaloshi G; Roci E; Rroji A; Ducray F; Petrela M
    J Neurosurg; 2015 Nov; 123(5):1244-6. PubMed ID: 26115464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen.
    Prados MD; Edwards MS; Rabbitt J; Lamborn K; Davis RL; Levin VA
    J Neurooncol; 1997 May; 32(3):235-41. PubMed ID: 9049885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemo-radiotherapy for malignant brain tumors].
    Kochi M; Ushio Y
    Gan To Kagaku Ryoho; 2002 May; 29(5):669-76. PubMed ID: 12040669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.